Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2023

Feb 21, 2023

61176_rns_2023-02-21_2557ba27-8818-498a-b2e4-9292ae3dd1dc.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

February 21, 2023

To,The SecretaryBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001 To,The SecretaryNational Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code - 532523 Scrip Symbol - BIOCON

Subject: Allotment of Non-Convertible Debentures on private placement basis

Dear Sir/ Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated November 14, 2022, we wish to inform you that the Company has issued and allotted unlisted, secured, rated, redeemable, non-convertible debentures of face value of INR 1,00,000/- (Rupees One Lakh only) each on private placement basis in 3 (three) Series, on the terms and conditions given below-

Sl. No. Particulars Remarks
1. Type of securities issued / allotted (viz.equityshares,convertibles etc.) Non-convertible debentures
2. Type of issuance (further public offering,rightsissue,depositoryreceipts(ADR/GDR),qualifiedinstitutionsplacement, preferential allotment etc.) Private Placement
3. Total number of securities issued / allotted 1,07,000 (One Lakh Seven Thousand) non-convertible debentures
4. Issue Size / the total amount for which thesecurities have been issued/allotted Rs. 10,70,00,00,000/- (Rupees One ThousandSeventyCrore only)
5. Number of Investor 1(One)
6. Name of Investor Fund managed by Kotak Investment AdvisorsLimited
7. Outcome of the subscription Fullysubscribed
8. Issue Price / Allotted Price per security Rs.1,00,000/-pernon-convertibledebentures
9. Whether proposed to be listed?Ifyes,name of the stock exchange No

==> picture [132 x 52] intentionally omitted <==

10. Tenure of the instrument 5 (five) years from the deemed date ofallotment
11. Date of Allotment February21,2023
12. Date of Maturity February21,2028
13. Coupon/Interest offered IRR of 12% p.a. plus variable coupon as perthe debenture trust deed
14. Schedule of payment of coupon/interestandprincipal Upon Redemption
15. Charge/security, if any, created over theassets First ranking exclusive charge by way ofpledge over specified number of equityshares of Biocon Biologics Limited held byBiocon Limited
16. Special rights/interest/privileges attachedto the instrument and changes thereof Put options exercisable as per the terms ofthe debenture trust deed
17. Delay in payment of interest/ principalamount for a period of more than 3 monthsfrom the due date or default in payment ofinterest/principal Not Applicable
18. Details of any letter or comments regardingpayment/non-paymentofinterest,principal on due dates, or any other matterconcerning the security and/or the assetsalongwith its comments thereon,if any Not Applicable
19. Details of redemption of debentures Redemption as per the terms of debenturetrust deed
20. Any cancellation or termination of proposalfor issuance of securities including reasonsthereof Not Applicable

The aforesaid information will also be available on the website of the Company at www.biocon.com.

We request you to take this on record.

Thanking You,

Yours faithfully,

For Biocon Limited

MAYA Digitally signed by MAYANK VERMA NK Date: 2023.02.21 VERMA 17:42:04 +05'30' _____________

Mayank Verma

Company Secretary and Compliance Officer Membership No.: ACS 18776